Food Allergy News

SAN ANTONIO — Although data are sparse, management strategies for children with food allergies often can be applied to adults, according to a presentation at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN ANTONIO — People with food allergies face multiple challenges when they travel by air, as airline responses to their needs vary, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN ANTONIO — Current health care services do not meet the psychological support needs of adults with food allergy in the United Kingdom, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN ANTONIO — Delayed and inaccurate diagnoses often plague patients with eosinophilic disorders, but online communities can help them cope, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN ANTONIO — Clinical decision support tools improved primary care providers’ adherence to early peanut introduction guidance during child wellness checks, according to study results.

SAN ANTONIO — Patients with higher reaction thresholds in their food allergies may be easier to treat with oral immunotherapy and see better outcomes, Scott H. Sicherer, MD, FAAP, said in this Healio exclusive video.

SAN ANTONIO — People with food allergy who also face food insecurity are at greater risk for a variety of mental health issues, according to survey data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN ANTONIO — The incidence of allergy to chia seed obtained from Salvia hispanica seems to be increasing, with co-sensitization to sesame, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Oral immunotherapy for egg or peanut allergy appeared safe for children on asthma medication despite greater bronchial hyperresponsiveness in this population, according to a study published in Clinical and Translational Allergy.

Adolescents with severe peanut allergy experienced clinically relevant improvements in health-related quality of life with oral immunotherapy and omalizumab, according to a letter published in Clinical and Translational Allergy.